Nurse cell of Trichinella spp. as a model of long-term cell cycle arrest

Cell Cycle

Volumn 7, Issue 14, 2008, Pages 2167-2178

  Dabrowska, Magdalena ^a   Skoneczny, Marek ^b   Zielinski, Zbigniew ^a   Rode, Wojciech ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

Cellular senescence; Competitive microarrays; Signaling networks; Trichinella spp. nurse cell

Indexed keywords

BETA GALACTOSIDASE; BETA SECRETASE; CELL DNA; CELL NUCLEUS RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE; EPIDERMAL GROWTH FACTOR; G PROTEIN COUPLED RECEPTOR; INHIBITOR OF DIFFERENTIATION PROTEIN; INHIBITOR OF DIFFERENTIATION PROTEIN 4; PROTEIN FOS; PROTEIN P15; PROTEIN P16; PROTEIN P57; RETINOIC ACID RECEPTOR; STAT6 PROTEIN; TRANSCRIPTION FACTOR FOSB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CELL AGING; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL SUSPENSION; CONTROLLED STUDY; CYTOPATHOLOGY; DNA CONTENT; GENETIC TRANSCRIPTION; MITOGENESIS; MODEL; MOUSE; MUSCLE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; NURSE CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRICHINELLA SPIRALIS; UNINDEXED SEQUENCE;

TRICHINA; TRICHINELLA; TRICHINELLA SPIRALIS;

EID: 47749127715     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.7.14.6269     Document Type: Article

References (86)

1. Despommier DD. Trichinella spiralis and the concept of niche. J Parasitol 1993; 79:472-82.
2. Boonmars T, Wu Z, Nagano I, Takahashi Y. Expression of apoptosis-related factors in muscles infected with Trichinella spiralis. Parasitology 2004; 128:323-32.
3. Gabryel P, Gustowska L, Blotna-Filipiak M. The unique and specific transformation of muscle cell infected with Trichinella spiralis. Basic Appl Myol 1995; 5:231-8.
4. Jasmer D P. Trichinella spiralis: subversion of differentiated mammalian skeletal muscle cells. Parasitol Today 1995; 11:185-8.
5. 2/M and cease muscle gene expression. J Cell Biol 1993; 121:785-93.
6. Matsuo A, Wu Z, Nagano I, Takahashi Y. Five types of nuclei present in the capsule of Trichinella spiralis. Parasitology 2000; 121:203-10.
7. Despommier DD. How does Trichinella spiralis make itself at home? Parasitol Today 1998; 14:318-23.
8. Wu Z, Matsuo A, Nakada T, Nagano I, Takahashi Y. Different response of satellite cells in the kinetics of myogenic regulatory factors and ultrastructural pathology after Trichinella spiralis and T. pseudospiralis infection. Parasitology 2001; 123:85-94.
9. Blagosklonny M V. Cell senescence and hypermitogenic arrest. EMBO Rep 2003; 4:358-62.
10. Baserga R. The cell cycle: myths and realities. Cancer Res 1990; 50:6769-71.
11. Mallette FA, Ferbeyre G. The DNA damage signaling pathway connects oncogenic stress to cellular senescence. Cell Cycle 2007; 6:1831-6.
12. Verde P, Casalino L, Talotta F, Yaniv M, Weitzman JB. Deciphering AP-1 function in tumorigenesis: fra-ternizing on target promoters. Cell Cycle 2007; 6:2633-9.
13. Pagliuca A, Gallo P, De Luca P, Lania L. Class A Helix-Loop-Helix proteins are positive regulators of several cyclin-dependent kinase inhibitors' promoter activity and negatively affect cell growth. Cancer Res 2000; 60:1376-82.
14. Kim MS, Sweeney TR, Shigenaga JK, Chui LG, Moser A, Grunfeld C, Feingold KR. Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPAR alpha, PPARgamma, LXRalpha and the coactivators SRC-1, PGC-1alpha and PGC-1beta in liver cells. Metabolism 2007; 56:267-79.
15. Han JDJ. Understanding biological functions through molecular networks. Cell Res 2008; 18:224-37.
16. Wu Z, Nagano I, Boonmars T, Takahashi Y. A spectrum of functional genes mobilized after Trichinella spiralis infection in skeletal muscle. Parasitology 2005; 130:561-73.
17. Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene 2005; 24:2899-08.
18. Helmbold H, Deppert W, Bohn W. Regulation of cellular senescence by Rb2/p130. Oncogene 2006; 25:5257-62.
19. Kitzmann M, Fernandez A. Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts. Cell Mol Life Sci 2001; 58:571-9.
20. Nurse P. Universal control mechanism regulating onset of M-phase. Nature 1990; 344:503-8.
21. Nurse P. Checkpoint pathways come of age. Cell 1997; 91:865-7.
22. 2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer. British J Cancer 2008; 98:523-8.
23. Xie S, Xie B, Lee MY, Dai W. Regulation of cell cycle checkpoints by polo-like kinases. Oncogene 2005; 24:277-86.
24. Maddika S, Ande SR, Panograhi S, Paranjothy T, Weglarczyk K, Zuse A, Eshraghi M, Manda KD, Wiechec E, Los M. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Res Updates 2007; 10:13-29.
25. Meek DW. The role of p53 in the response to mitotic spindle damage. Pathol Biol (Paris) 2000; 48:246-54.
26. Ta o W. The mitotic checkpoint in cancer therapy. Cell Cycle 2005; 4:1495-9.
27. Boonmars T, Wu Z, Nagano I, Takahashi Y. What is the role of p53 during the cyst formation of Trichinella spiralis? A comparable study between knockout mice and wild type mice. Parasitology 2005; 131:705-12.
28. Kortlever RM, Higgins PJ, Bernards R. Plasminogen activator inhibitor-1 is a crucial downstream target of p53 in the induction of replicative senescence. Nat Cell Biol 2006; 8:877-84.
29. Tang X, Milyavsky M, Goldfinger N, Rotter V. Amyloid-β precursor-like protein APLP1 is a novel p53 transcriptional target gene that augments neuroblastoma cell death upon genotoxic stress. Oncogene 2007; 26:7302-12.
30. 2/M transition by p53. Oncogene 2001; 20:1803-15.
31. Blagosklonny M V. Mitotic arrest and cell fate. Why and how mitotic inhibition of transcription drives mutually exclusive events. Cell Cycle 2007; 6:70-4.
32. Schmitt E, Paquet C, Beauchemin M, Bertrand R. DNA-damage response network at the crossroads of cell cycle checkpoints, cellular senescence and apoptosis. J Zhejiang Univ Sci B 2007; 8:377-97.
33. Schmitt CA. Senescence, apoptosis and therapy-cutting the lifelines of cancer. Nat Rev Cancer 2003; 3:286-95.
34. Campisi J, Adda di Fagana F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8:729-40.
35. Ha L, Ichikawa T, Anver M, Dickens R, Lowe S, Sharpless NE, Krimpenfort P, DePinho RA, Bennett DC, Sviderskaya EV, Merlino G. ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence. Proc Natl Acad Sci USA 2007; 104:10968-73.
36. Sherr CJ. Divorsing ARF and p53: an unsettled case. Nat Rev Cancer 2006; 6:663-73.
37. Singh AB, Harris RC. Autocrine, paracrine and juxtacrine signaling by EGFR ligands. Cell Signal 2005; 17:1183-93.
38. 2 biosynthesis by cardiomyocyte. J Biol Chem 2006; 281:16443-52.
39. Chaturvedi V, Cesnjaj M, Bacon P, Panella J, Choubey D, Diaz MO, Nickoloff BJ. Role of INK4a/Arf locus-encoded senescent checkpoints activated in normal and psoriatic kerati-nocytes. Am J Pathol 2003; 162:161-70.
40. Gomis RR, Alarcon C, He W, Wang Q, Seoene J, Lash A, Massague J. A FoxoO-Smad synexpression group in human keratinocytes. Proc Natl Acad Sci USA 2006; 103:12747-52.
41. Attisano L, Wrana JL. Signal transduction by TGFβ superfamily. Science 2002; 296:1646-7.
42. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005; 120:513-22.
43. Bavik C, Coleman I, Dean J, Knudsen B, Plymate S, Nelson PS. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Caner Res 2006; 66:794-802.
44. Krtolica A, Campisi J. Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int J Biochem Cell Biol 2002; 34:1401-14.
45. Martens JW, Sieuwerts AM, Bolt-de-Vries J, Bosma P T, Swigers SJ, Klijn JG, Foekens JA. Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression. Thromb Haemost 2003; 89:393-404.
46. Coppe J P, Kauser K, Campisi J, Beausejour CM. Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. J Biol Chem 2006; 281:29568-74.
47. Doucet C, Jasmin C, Azzarone B. Unusual interleukin-4 and-13 signaling in human normal and tumor lung fibroblasts. Oncogene 2000; 30:5898-905.
48. Lassar AB, Thayer MJ, Overell RW, Weintraub H. Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1. Cell 1989; 58:659-67.
49. Brookes S, Rowe J, Ruas M, Llanos S, Clark PA, Lomax M, James MC, Vatcheva R, Bates S, Vousden KH, Parry D, Gruis N, Smit N, Bergman W, Peters G. INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence. EMBO J 2002; 21:2936-45.
50. INK4b. Mol Cell Biol 2000; 20:2915-25.
51. Wang W, Chen JX, Liao R, Deng Q, Zhou JJ, Huang S, Sun P. Sequential activation of the MEK-extracellular signal-regulated kinase MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol Cell Biol 2002; 22:3389-403.
52. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70.
53. Joo CK, Kim HS, Park JY, Seomun Y, Son MJ, Kim J T. Ligand release-independent trans-activation of epiderma growth factor receptor by transforming growth factor-β involves multiple signaling pathways. Oncogene 2008; 27:614-28.
54. Amit I, Wides R, Yarden Y. Evolvable signaling networks of receptor tyrosine kinases: relevance of robustness to malignancy and to cancer therapy. Mol Systems Biol 2007; 3:1-14.
55. Oh JS, Kucab JE, Bushel PR, Martin K, Bennett L, Collins J, DiAugustine R P, Barrett JC, Afshari CA, Dunn SE. Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells. Neoplasia 2002; 4:204-17.
56. Lo YYC, Luo L, McCulloch CAG, Cruz T F. Requirement of focal adhesions and calcium fluxes for interleukin-1-induced ERK kinase activation and c-fos expression in fibroblasts. J Biol Chem 1998; 273:7059-65.
57. Thompson PW, Randi AM, Ridley AJ. Intrcellular adhesion molecule (ICAM)-1, but not ICAM-2, activates RhoA and stimulates c-fos and rhoA transcription in endothelial cells. J Immunol 2002; 169:1007-13.
58. Wei X, Ni S, Correll PH. Unoupling ligand-dependent and -independent mechanisms for mitogen-activated protein kinase activation by the murine Ron receptor tyrosine kinase. J Biol Chem 2005; 280:35098-107.
59. Xie GX, Palmer P P. How regulators of G protein signaling achieve selective regulation. J Mol Biol 2007; 366:349-65.
60. Rozengurt E. Mitogenic signaling pathways induced by G protein-coupled receptors. J Cell Physiol 2007; 213:589-602.
61. Sands WA, Palmer TM. Regulating gene transcription in response to cyclic AMP elevation. Cell Signal 2008; 20:460-6.
62. Garattini E, Gianni M, Terao M. Retinoids as differentiating agents in oncology: a network of interactions with intracellular pathways as the basis for rational therapeutic combinations. Curr Pharm Des 2007; 13:1375-400.
63. Shay J W, Roninson IB. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 2004; 23:2919-33.
64. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM. Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors. Nature 1992; 358:771-4.
65. Zhang XK, Hoffman B, Tran PB, Graupner G, Pfahl M. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 1992; 355:441-9.
66. Teofili L, Morosetti R, Martini M, Urbano R, Putzulu R, Rutella S, Pierelli L, Leone G, Larocca LM. Expression of cyclin-dependent kinase inhibitor p15(INK4B) during normal and leukemic myeloid differentiation. Exp Hematol 2000; 28:519-26.
67. Wainwright LJ, Lasorella A, Iavarone A. Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells. Proc Natl Acad Sci USA 2001; 98:9396-400.
68. Roninson IB, Dokmanovic M. Induction of senescence-associated growth inhibitors in the tumor-suppressive function of retinoids. J Cell Biochem 2003; 88:83-94.
69. Naka K, Tachibana A, Ikeda K, Motoyama N. Stress-induced premature senescence in hTERT-expressing ataxia telangiectasia fibroblasts. J Biol Chem 2004; 279:2030-7.
70. Arf to nitric oxide-dependent apoptosis. J Immunol 2006; 177:3327-36.
71. Fiscus RR. Involvement of cyclic GMP and protein kinase G in the regulation of apoptosis and survival in neural cells. Neurosignals 2002; 11:175-90.
72. Lincoln TM, Wu X, Sellak H, Dey N, Choi CS. Regulation of vascular smooth muscle cell phenotype by cyclic GMP and cyclic GMP-dependent protein kinase. Front Biosci 2006; 11:356-67.
73. Shin JY, Kim HS, Park J, Park JB, Lee JY. Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells. Cancer Res 2000; 60:262-5.
74. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, Micheva KD, Mehalow AK, Huberman AD, Stafford B, Sher A, Litke AM, Lambris JD, Smith SJ, John SW, Barres BA. The classical complement cascade mediates CNS synapse elimination. Cell 2007; 131:1164-78.
75. Mimeault M, Hauke R, Metha P P, Batra SK. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med 2007; 11:981-1011.
76. Powers S, Mu D. Genetic similarities between organogenesis and tumorigenesis of the lung. Cell Cycle 2008; 7:200-4.
77. Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ, Keller CK, Rando TA. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 2007; 317:807-10.
78. Liu H, Fergusson MM, Castilho RM, Liu J, Cao L, Chen J, Malide D, Rovira II, Schimel D, Kuo CJ, Gutkind JS, Hwang PM, Finkel T. Augmented Wnt signaling in a mammalian model of accelerated aging. Science 2007; 317:803-6.
79. van Kempen LCL, de Visser KE, Cousens LM. Inflammation, proteases and cancer. Eur J Cancer 2006; 42:728-34.
80. de Visser KE, Coussens LM. The interplay between innate and adaptive immunity regulates cancer development. Cancer Immunol Immuther 2005; 54:1143-52.
81. Dabrowska M, Zielinski Z, Wranicz M, Michalski R, Pawelczak K, Rode W. Trichinella spiralis thymidylate synthase: developmental pattern, isolation, molecular properties, and inhibition by substrate and cofactor analogues. Biochem Biophys Res Commun 1996; 228:440-5.
82. Jasmer D P. Trichinella spiralis: altered expression of muscle proteins in trichinosis. Exp Parasitol 1990; 70:452-65.
83. Montgomery J, Feldman A, Despommier DD, Stewart GL, Haehlig E. A method for isolation and partial purification of Trichinella spiralis nurse cells. J Parasitol 1995; 81:649-52.
84. Lengen RCJ, Schols AMWJ, Kelders CJM, Woulters EFM, Janssen-Heininger YMW. Enhanced myogenic differentiation by extracellular matrix is regulated at the early stages of myogenesis. In Vitro Cell Dev Biol-Animal 2003; 39:163-9.
85. Travaglione S, Messina G, Fabbri A, Falzano L, Giammarioli AM, Grossi M, Rufini S, Fiorentini C. Cytotoxic necrotizing factor 1 hinders skeletal muscle differentiation in vitro by perturbing the activation/deactivation balance of Rho GTPases. Cell Death Differ 2005; 12:78-85.
86. User Bulletin#2 ABI PRISM 7700 Sequence Detection Systems. Applied Biosystems 1997.